Article thumbnail

A comprehensive review of the literature on epilepsy in selected countries in emerging markets

By Mallik Angalakuditi and Nupur Angalakuditi
Topics: Review
Publisher: Dove Medical Press
OAI identifier: oai:pubmedcentral.nih.gov:3191871
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A pharmacoeconomic analysis of the impact of therapeutic drug monitoring in adult patients with generalized tonic-clonic epilepsy.
  2. A prevalence study of epilepsy in Hong Kong. Hong Kong Med
  3. A systematic review of the epidemiology of epilepsy in Arab countries.
  4. (2011). Against Epilepsy [homepage]. Available at: www.
  5. Antiepileptic drug withdrawal after successful surgery for intractable temporal lobe epilepsy.
  6. (2011). Available at: http://www.who.int/mediacentre/factsheets/fs999/ en/index.html.
  7. BIA-2093-301 Investigators Study Group. Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study.
  8. BIA-2093-301 Study Group. Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy.
  9. Burden of intractable epilepsy.
  10. Clinical and demographic characteristics predicting QOL in patients with epilepsy in the Czech Republic: how this can influence practice.
  11. Clinical trials of antiepileptic medications in newly diagnosed patients with epilepsy.
  12. Clobazam as add-on therapy for temporal lobe epilepsy and hippocampal sclerosis.
  13. Commission on European Affairs: appropriate standards of epilepsy care across Europe.
  14. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
  15. Comparison of add-on valproate and primidone in carbamazepine-unresponsive patients with partial epilepsy.
  16. Cost of epilepsy: a systematic review.
  17. Death anxiety in patients with epilepsy.
  18. Development of a validated clinical case definition of generalized tonic-clonic seizures for use by community-based health care providers.
  19. (2006). Direct medical costs for partial refractory epilepsy in Mexico. Arch Med Res.
  20. Economic burden of epilepsy in a developing country: a retrospective cost analysis in China.
  21. (2009). Economic Evaluation of Add-on Levetiracetam for the Treatment of Refractory Partial Epilepsy in Korea. Psychiatry Investig.
  22. (2011). Efficacy and safety of adjunctive zonisamide in adult patients with refractory partial-onset epilepsy: a randomized, double-blind, placebo-controlled trial. Clin Drug Investig.
  23. Efficacy and safety of levetiracetam (3,000 mg/Day) as an adjunctive therapy in Chinese patients with refractory partial seizures.
  24. Efficacy and safety of levetiracetam (up to 2000 mg/day) in Taiwanese patients with refractory partial seizures: a multicenter, randomized, double-blind, placebo-controlled study.
  25. Efficacy and safety of levetiracetam as adjunctive therapy in adult patients with uncontrolled partial epilepsy: the Asia SKATE II Study. Epilepsy Behav.
  26. Efficacy and safety of the monoand combined therapy with oxcarbazepine in adult patients.
  27. Efficacy and tolerability of the new anti-epileptic drugs II: Treatment of refractory epilepsy.
  28. Efficacy of clobazam as add-on therapy in patients with refractory partial epilepsy.
  29. Efficacy of topiramate in adult patients with symptomatic epilepsy: an open-label, long-term, retrospective observation.
  30. Epidemiological survey of epilepsy in the primary school population in Buenos Aires.
  31. Epidemiological survey of epilepsy in the special school population in the city of Buenos Aires. A comparison with mainstream schools.
  32. (2001). Epidemiology of childhood epilepsy in a cohort of 309 Chinese children. Pediatr Neurol.
  33. Epilepsy care in six Indian cities: a multicenter study on management and service.
  34. Epilepsy control with phenobarbital or phenytoin in rural south India: the Yelandur study.
  35. (2009). Epilepsy Fact Sheet No 999,
  36. Epilepsy in Colombia: epidemiologic profile and classification of epileptic seizures and syndromes.
  37. Epilepsy in North America: a report prepared under the auspices of the global campaign against epilepsy, the International Bureau for Epilepsy, the International League Against Epilepsy, and the World Health Organization.
  38. Epilepsy prevalence in a rural area in Istanbul.
  39. (2008). Evaluation of the factors affecting the quality of life and total costs in epilepsy patients on monotherapy with carbamazepine and valproate. Folia Med
  40. Experience in the use of the anticonvulsant pregabalin as an add-on therapy in patients with partial epilepsy with polymorphic seizures.
  41. (2005). Frequent seizures and polytherapy can impair quality of life in persons with epilepsy. Neurol
  42. (2002). Gabapentin and lamotrigine in Indian patients of partial epilepsy refractory to carbamazepine. Neurol
  43. Gabapentin withdrawal syndrome in the presence of a taper. Bipolar Disord.
  44. GABI-balance – a non-interventional observational study on the effectiveness of tiagabine in add-on therapy in partial epilepsy.
  45. Gulf Vipe Study Group. Short-term efficacy and safety of valproate sustainedrelease formulation in newly diagnosed partial epilepsy VIPe-study. A multicenter observational open-label study.
  46. ILAE Commission of European Affairs Subcommission on European Guidelines 1998–2001: The provision of epilepsy care across Europe.
  47. Lacosamide: in partial-onset seizures.
  48. Less commonly used antiepileptic drugs. The treatment of epilepsy: principles and practice. 4
  49. Long-term efficacy and tolerability of topiramate as add-on therapy in refractory partial epilepsy: an observational study.
  50. Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents.
  51. Magureanu S; VIPe Study Group. An observational study of first-line valproate monotherapy in focal epilepsy.
  52. Monotherapy of epilepsy in women: psychiatric and neuroendocrine aspects.
  53. Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in Chinese patients with refractory partial-onset seizures.
  54. New statistical method for analyzing time to first seizure: example using data comparing carbamazepine and valproate monotherapy.
  55. Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy.
  56. Pharmacotherapy of epilepsy: newly approved and developmental agents.
  57. (2006). Population-based survey on prevalence of adult patients with epilepsy in Taiwan (Keelung community-based integrated screening no.12). Epilepsy Res.
  58. (2009). Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial. Epilepsia.
  59. Prevalence and clinical features of epilepsy in Argentina. A community-based study.
  60. Prevalence of epilepsy in Bursa city center, an urban area of Turkey.
  61. (2010). Prevalence of epilepsy in northeast Turkey. Epileptic Disord.
  62. Prevalence of epilepsy in school-going children (6–18 years) in Kashmir Valley of North-west India.
  63. Prevalence of epilepsy in Turkish children between the ages of 0 and 16 years.
  64. Primary care treatment of epilepsy with phenobarbital in rural China: cost-outcome analysis from the WHO/ ILAE/IBE global campaign against epilepsy demonstration project.
  65. (1989). Proposal for revised classification of epilepsies and epileptic syndromes.
  66. Public knowledge and attitudes toward epilepsy in Kuwait.
  67. Seizure disorders.
  68. SP755 Study Group. Adjunctive lacosamide for partial-onset seizures: Efficacy and safety results from a randomized controlled trial.
  69. Spike-and-wave complexes and seizure exacerbation caused by carbamazepine.
  70. Status epilepticus in resource-poor countries.
  71. The cost of epilepsy in the United States: an estimate from population-based clinical and survey data.
  72. (2009). The descriptive epidemiology of epilepsy-a review. Epilepsy Res.
  73. (2010). The operational model of a network for managing patients with convulsive epilepsy in rural West China. Epilepsy Behav.
  74. The prevalence of epilepsy and other seizure disorders in an Arab population: a community-based study.
  75. Tiagabine as add-on therapy may be more effective with valproic acid – open label, multicentre study of patients with focal epilepsy.
  76. Time course of adverse events in patients with localization-related epilepsy receiving topiramate added to carbamazepine.
  77. (2007). Tolerability and safety of topiramate in Chinese patients with epilepsy: an open-label, long-term, prospective study. Clin Drug Investig.
  78. Vagus nerve stimulation for refractory epilepsy: long term efficacy and side-effects.
  79. (2009). What Is An Emerging Market Economy?